Asset Details
Do you wish to reserve the book?
Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly
Do you wish to request the book?
Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly
2025
Overview
Cardio-rheumatology is an evolving and interdisciplinary field lying at the intersection of rheumatology and cardiovascular medicine that recognizes that individuals with autoimmune and inflammatory rheumatic complications have a much higher likelihood of developing cardiovascular diseases (CVDs). Inflammasomes are multiprotein complexes stimulated by the immune system after the detection of pathogens or cellular injury. Inflammasomes undergo a two-stage activation process initiated by nuclear factor (NF)-κB, subsequently playing a crucial role in innate immunity through activation of caspase 1 and the consequent release of proinflammatory cytokines such as IL-18 and IL-1β. However, a loss of control of inflammasome activation can cause inflammatory diseases in humans. Recent studies have focused on the role of inflammasomes in inflammatory cascades implicated in the pathogenesis of several diseases. Here, we review inflammasome activation, its mechanism of action, and its role in CVD. In particular, we describe the role of inflammasomes in rheumatic heart disease, Kawasaki disease, familial Mediterranean fever, ankylosing spondylitis, and rheumatoid arthritis as exemplars to illustrate pathobiological mechanisms and the potential for targeting inflammasomes for therapeutic benefit.
Publisher
MDPI AG,MDPI
Subject
/ Cardiovascular Diseases - metabolism
/ Enzymes
/ Humans
/ Mucocutaneous Lymph Node Syndrome - immunology
/ Mucocutaneous Lymph Node Syndrome - metabolism
/ Mucocutaneous Lymph Node Syndrome - pathology
/ Proteins
/ Review
/ Rheumatic Diseases - immunology
/ Rheumatic Diseases - metabolism
/ Rheumatic Heart Disease - immunology
